| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $173.8M | +42.9% |
| SG&A Expense | $34.4M | +31.1% |
| Operating Income | -$208.1M | -40.8% |
| Net Income | -$192.4M | -37.2% |
| EPS (Basic) | -$2.42 | -1.3% |
| EPS (Diluted) | -$2.42 | -1.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.2M | -61.9% |
| Current Assets | $270.8M | +2.2% |
| Total Assets | $313.4M | +4.2% |
| Current Liabilities | $38.2M | +42.2% |
| Total Liabilities | $55.6M | +23.4% |
| Stockholders' Equity | $257.8M | +0.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$153.6M | -29.5% |
| Capital Expenditures | $2.8M | -59.3% |
| Investing Cash Flow | -$97.8M | +21.6% |
| Financing Cash Flow | $163.5M | -0.0% |
| Free Cash Flow | -$156.4M | -24.6% |